C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/29/2007	US20070275917 Rna Capable of Suppressing Expression of Klf5 Gene
11/29/2007	US20070275916 Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)
11/29/2007	US20070275915 Tmprss2 Regulatory Sequences and Uses Thereof
11/29/2007	US20070275914 Therapeutic Compositions
11/29/2007	US20070275913 Compositions and their uses directed to hepcidin
11/29/2007	US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007	US20070275889 Gene Expression Technique
11/29/2007	US20070275887 Method of Inhibiting Secretase Activity
11/29/2007	US20070275873 Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting
11/29/2007	US20070275872 Peptides with Anti-Obesity Activity and Other Related Uses
11/29/2007	US20070275466 Methods of modifying genes in eukaryotic cells
11/29/2007	US20070275465 consisting of two single strands that exhibits increased effectiveness in inhibiting the expression of a target gene by means of RNA interference; improved stability in cells
11/29/2007	US20070275464 Chitin Oligosaccharide Elicitor-Binding Proteins
11/29/2007	US20070275449 Method for Large-Scale Production, Isolation, Purification and the Uses of Multi-Type Recombinant Adeno-Associated Virus Vectors
11/29/2007	US20070275443 Random Drift Mutagenesis
11/29/2007	US20070275441 Ocular Tissue Modification
11/29/2007	US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007	US20070275438 Compositions and Methods for Producing Fermentation Products and Residuals
11/29/2007	US20070275437 Antibodies to G protein-coupled receptor
11/29/2007	US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
11/29/2007	US20070275419 Tumor tag and the use thereof
11/29/2007	US20070275407 Methods for determining therapeutic index from gene expression profiles
11/29/2007	US20070275405 Member for producing a probe array and probe array producing method
11/29/2007	US20070275397 Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/29/2007	US20070275395 Tagged monomers for use in sequence determination
11/29/2007	US20070275393 Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
11/29/2007	US20070275391 Novel g-protein coupled receptors and dna sequences thereof
11/29/2007	US20070275385 Rapid Screening Method of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom
11/29/2007	US20070275384 Assessing human predisposition to a febrile seizure disorder
11/29/2007	US20070275377 Isolated Photoprotein mtClytin, and Use Thereof
11/29/2007	US20070275376 Tumor-Specific Expression of Reporter Genes
11/29/2007	US20070275375 Means and Method for the Detection of Target Nucleotide Sequences Using Ligation Assays With Improved Oligonucleotide Probe Pairs
11/29/2007	US20070275373 Method of fingerprinting tissue samples
11/29/2007	US20070275368 Posh Associated Kinases And Related Methods
11/29/2007	US20070275099 MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
11/29/2007	US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007	US20070275037 Recombinant vitellogenin enriched feed
11/29/2007	US20070275029 Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders
11/29/2007	US20070275018 Relates to gene NcSAG4, the RNA messenger of said gene, the oligonucleotides designed based on the nucleotide sequence thereof, and to protein NcSAG4 encoded thereby, and expression vectors, for the purpose of diagnosis and vaccination for the prevention of neosporosis
11/29/2007	US20070275016 Kennel cough vaccine
11/29/2007	US20070275011 Inducible Bacterial Expression System Utilising Sspa Promoter from Salmonella
11/29/2007	US20070275010 Mva Vaccines
11/29/2007	US20070275004 Group b streptococcus antigens
11/29/2007	US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007	US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007	US20070275000 Tick Engorgement Factor Proteins
11/29/2007	US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007	US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007	US20070274996 IL-4R antagonists; allergies and asthma
11/29/2007	US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007	US20070274973 Method of controlling fungal pathogens, and agents useful for same
11/29/2007	US20070274971 Method of Proliferating Precursor Cells
11/29/2007	US20070274954 Cloning B and T lymphocytes
11/29/2007	US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007	US20070274952 Compositions and Methods for Modifying the Content of Polyunsaturated Fatty Acids in Biological Cells
11/29/2007	US20070274950 Interferon-alpha polypeptides and conjugates
11/29/2007	US20070274947 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer
11/29/2007	US20070274936 Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent
11/29/2007	US20070274916 Method for Identifying Compounds that Affect Expression of Tryptophan Hydroxylase Isoform 2
11/29/2007	US20070274915 Modulation Of Anergy And Methods For isolating Anergy-Modulating Compounds
11/29/2007	US20070272998 Semiconductor Device
11/29/2007	DE102006026191A1 Vorrichtung und Substanz zur Isolierung von mesenchymalen Stammzellen (MSC) Apparatus and substance for the isolation of mesenchymal stem cells (MSC)
11/29/2007	CA2843961A1 Use of non-agrobacterium bacterial species for plant transformation
11/29/2007	CA2654467A1 Prostate epithelial androgen receptor suppresses prostate growth and tumor invasion
11/29/2007	CA2654415A1 Protein production using eukaryotic cell lines
11/29/2007	CA2653451A1 Compositions and methods for inhibiting expression of ikk-b gene
11/29/2007	CA2653104A1 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity
11/29/2007	CA2653052A1 Treatment of protein misfolding
11/29/2007	CA2652886A1 High affinity human and humanized anti-.alpha.5.beta.1 integrin function blocking antibodies with reduced immunogenicity
11/29/2007	CA2652770A1 Rnai modulation of aha and therapeutic uses thereof
11/29/2007	CA2652689A1 Method of constructing gene transport support
11/29/2007	CA2652598A1 Artificial plant minichromosomes
11/29/2007	CA2652595A1 Defective interfering virus
11/29/2007	CA2652538A1 Fusion proteins, uses thereof and processes for producing same
11/29/2007	CA2652408A1 Means and method for inducing exon-skipping
11/29/2007	CA2652377A1 Use of non-agrobacterium bacterial species for plant transformation
11/29/2007	CA2652052A1 Nucleic acid separation and purification method based on reversible charge interactions
11/29/2007	CA2651907A1 Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants
11/29/2007	CA2651456A1 Recombinant vectors
11/29/2007	CA2650548A1 Method for performing homologous recombination in plants
11/29/2007	CA2650416A1 Rnai-mediated inhibition of tumor necrosis factor .alpha.-related conditions
11/29/2007	CA2650414A1 Methods and compositions for inactivation of dihydrofolate reductase
11/29/2007	CA2649722A1 Use of an antibody
11/29/2007	CA2647215A1 Delta-5 desaturase and its use in making polyunsaturated fatty acids
11/29/2007	CA2647198A1 Delta-5 desaturase from peridinium sp. and its use in making polyunsaturated fatty acids
11/29/2007	CA2637988A1 Anti-fgf19 antibodies and methods using same
11/29/2007	CA2590552A1 Methods and compositions for depleting mitochondrial dna
11/28/2007	EP1860438A1 Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein
11/28/2007	EP1860437A1 Evaluation method for skin condition utilizing squamous cell carcinoma-related antigen as measure
11/28/2007	EP1860199A2 Modulating insulin receptor signaling
11/28/2007	EP1860193A1 Promoter-activity modulation for branched-chain amino acid production
11/28/2007	EP1860192A1 Compositions and methods for treating intracellular diseases
11/28/2007	EP1860191A2 Combination neisserial compositions
11/28/2007	EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007	EP1860189A1 Human gene
11/28/2007	EP1860188A2 Human cytokine receptor
11/28/2007	EP1860187A1 Apo-2 receptor
11/28/2007	EP1860186A2 Method for distinguishing mesenchymal stem cells using different markers
11/28/2007	EP1860185A1 Screening method
11/28/2007	EP1860184A1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide

1 ... 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 ... 4023